Company page

Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. is a public biotechnology company traded under the ticker XLO in the American market. With a market capitalization of approximately $57.8 million, Xilio focuses on developing innovative therapies for cancer treatment. The company is committed to advancing its research and development efforts to improve patient outcomes.